1. Effect ofDendrobium moniliformeon Melanogenic Protein Expression in B16F10 Melanoma Cells
- Author
-
Yeong-Jong Ko, Sang-Mok Song, Weon-Jong Yoon, Kee-Hwa Bae, and Soo Kyung Yang
- Subjects
Pharmacology ,Gene isoform ,Dendrobium moniliforme ,biology ,Tyrosinase ,Plant Science ,Toxicology ,biology.organism_classification ,Microphthalmia-associated transcription factor ,Agricultural and Biological Sciences (miscellaneous) ,Hyperpigmentation ,eye diseases ,Blot ,Complementary and alternative medicine ,Biochemistry ,Drug Discovery ,medicine ,medicine.symptom ,Transcription factor ,Gene - Abstract
The Dendrobium moniliforme extract (DME) was successively partitioned using n-hexane, CH2Cl2, EtOAc, BuOH, and water. The results indicate that the Dendrobium moniliforme fraction extracted using CH2Cl2 (DMC) was an effective inhibitor of melanogenesis in murine melanoma cells (B16F10). To elucidate the mechanism of the effect of DME on melanogenesis, we performed western blotting of the melanogenic proteins. DME inhibited tyrosinase and, tyrosinase-related protein-1 (TRP-1) and TRP-2 expressions. Futher, we confirmed that DME decreased the protein level of melanocyte-specific isoform of microphthalmia-associated transcription factor (MITF) proteins, which decreased tyrosinase and related genes in B16F10 melanoma cells. On the basis of the results, we suggest that D. moniliforme is effective against hyperpigmentation disorders and that it be considered a possible anti-melanogenic agent in topical application.
- Published
- 2015
- Full Text
- View/download PDF